Results 31 to 40 of about 3,203 (180)

Enhanced renoprotective actions of Paricalcitol and omega-3 fatty acids co-therapy against diabetic nephropathy in rat

open access: yesJournal of Advanced Research, 2022
Introduction: Although the synthetic vitamin D analogue, Paricalcitol, and omega-3 Fatty acids (ω-3) alleviated diabetic nephropathy (DN), their combination was not previously explored.
Mohamed El-Boshy   +10 more
doaj   +1 more source

Paricalcitol Pretreatment Attenuates Renal Ischemia-Reperfusion Injury via Prostaglandin E2 Receptor EP4 Pathway [PDF]

open access: yes, 2017
The protective mechanism of paricalcitol remains unclear in renal ischemia-reperfusion (IR) injury. We investigated the renoprotective effects of paricalcitol in IR injury through the prostaglandin E2 (PGE2) receptor EP4.
Yu Ah Hong   +11 more
core   +1 more source

Three Therapeutic Strategies: Cinacalcet, Paricalcitol or Both in Secondary Hyperparathyroidism Treatment in Hemodialysed Patients During 1-Year Observational Study—A Comparison

open access: yesFrontiers in Endocrinology, 2019
Introduction: Secondary hyperparathyroidism (sHPT) is a common hormonal complication of chronic kidney disease. There are several therapeutic options for sHPT management aiming at calcium-phosphorus balance normalization and decrease of parathormone ...
Jacek Zawierucha   +5 more
doaj   +1 more source

Effect of paricalcitol vs calcitriol on hemoglobin levels in chronic kidney disease patients: a randomized trial. [PDF]

open access: yesPLoS ONE, 2015
Recent studies suggest that vitamin D deficiency represents an additional cofactor of renal anemia, with several mechanisms accounting for this relationship.
Eleonora Riccio   +6 more
doaj   +1 more source

Antioxidant and renoprotective effects of paricalcitol on experimental contrast-induced nephropathy model

open access: yes, 2012
Objectives: The aim of the study was to assess the effect of paricalcitol on the experimental contrast-induced nephropathy (CIN) model. We hypothesised that paricalcitol may prevent CIN.
ÖZEN ALAHDAB, YEŞİM
core   +2 more sources

Efecto regulador de paricalcitol sobre parámetros inflamatorios, fibróticos y anticalcificantes en el paciente con enfermedad renal crónica. Más allá de la regulación de la enfermedad óseo-mineral

open access: yesNefrología, 2020
Resumen: Antecedentes: La principal causa de morbimortalidad en el paciente con enfermedad renal crónica (ERC) es la cardiovascular. La inflamación y las alteraciones en el metabolismo óseo-mineral en estos pacientes conllevan aumento del riesgo ...
Laura Salanova Villanueva   +3 more
doaj   +1 more source

Combination Therapy with Enalapril and Paricalcitol Ameliorates Streptozotocin Diabetes-Induced Testicular Dysfunction in Rats via Mitigation of Inflammation, Apoptosis, and Oxidative Stress

open access: yesPathophysiology, 2023
Background: As the impacts of diabetes-induced reproductive damage are now evident in young people, we are now in urgent need to devise new ways to protect and enhance the reproductive health of diabetic people.
Magdy Y. Elsaeed   +17 more
doaj   +1 more source

Paricalcitol Protects Peritoneal Membrane Function in Encapsulating

open access: yes, 2016
OBJECTIVE: The most lethal complication of peritoneal dialysis is encapsulating peritoneal sclerosis (EPS), which develops as a result of epithelio-mesenchymal transformation (EMT) and known fibrotic processes.
Yıldız, Abdülmecit   +21 more
core   +1 more source

Paricalcitol versus Calcitriol + Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease in China: A Cost-Effectiveness Analysis

open access: yesFrontiers in Public Health, 2021
Background: Chronic Kidney Disease (CKD) is a global chronic disease with increasing prevalence in recent years, particularly CKD accompanied by Secondary Hyperparathyroidism (SHPT) leads to reduced quality of life, increased mortality, a considerable ...
Zhuolin Zhang   +10 more
doaj   +1 more source

Effects of calcitriol and paricalcitol on renal fibrosis in CKD

open access: yesNephrology Dialysis Transplantation, 2021
Abstract Background In chronic kidney disease, the activation of the renin–angiotensin–aldosterone system (RAAS) and renal inflammation stimulates renal fibrosis and the progression to end-stage renal disease.
Laura Martínez-Arias   +13 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy